Principles and problems of transfusion in sickle cell disease

Seminars in Hematology

Volumn 38, Issue 4, 2001, Pages 315-323

  Telen, Marilyn J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

ALLOIMMUNIZATION; BACTEREMIA; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RH; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; HEALING; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON OVERLOAD; PREGNANCY; PREOPERATIVE CARE; PRIAPISM; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; STROKE; TREATMENT INDICATION; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 0034778419     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(01)90025-3     Document Type: Article

References (86)

1. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
2. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients
3. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy
4. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases
5. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease
6. Combined sickle cell disease and autoimmune hemolytic anemia
7. Eye disease in sickling disorders
8. Abnormal rheology of oxygenated blood in sickle cell anemia
9. Desferioxamine ototoxicity in an adult transfusion-dependent population
10. Excretion of iron in response to deferoxamine in sickle cell anemia
11. A modified transfusion program for prevention of stroke in sickle cell disease
12. Erythrocyte autoantibodies induced in mice immunized with rat erythrocytes
13. Impaired regulation of erythrocyte autoantibody production after splenectomy
14. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
15. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: Use of steroids and intravenous immunoglobulin to prevent further red cell destruction
16. Pregnancy and sickle cell hemoglobinopathies: Results with and without prophylactic transfusions
17. Cytokine roles in hemolytic and nonhemolytic transfusion reactions
18. Red cell alloimmunization in sickle cell disease
19. Prevalence of hepatitis C in adults with sickle cell disease
20. Delayed hemolytic transfusion reaction presenting as sickle cell crisis
21. Priapism and impotence in homozygous sickle cell disease
22. Acute splenic sequestration in homozygous sickle cell disease: Natural history and management
23. Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease
24. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history, and sequelae
25. Transfusion therapy in sickle cell disease
26. Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the National Preoperative Transfusion Study
27. Priapism as a complication of sickle cell disease
28. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy
29. Chronic hepatitis C in patients with sickle cell disease
30. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes
31. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients
32. Pregnancy in sickle cell disease in the UK: Results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome
33. Blood transfusion in pregnancies complicated by maternal sickle cell disease. Effects on blood rheology and uteroplacental Doppler velocimetry
34. Molecular biology and genetics of the Rh blood group system
35. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients' red cells
36. Long-term management of splenic sequestration in children with sickle cell disease
37. Prophylactic red cell transfusion in pregnant patients with sickle cell disease. A randomized cooperative study
38. u category III) phenotype
39. Mortality in children and adolescents with sickle cell disease
40. A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction
41. Prophylactic versus selective blood transfusion for sickle cell anaemia during pregnancy
42. Posttransfusion crises in sickle cell anemia: Role of delayed hemolytic reactions to transfusion
43. Experimental production in man of autoantibodies with Rh specificity
44. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state
45. Survival after intrahepatic cholestasis associated with sickle cell disease
46. Beneficial effect of blood transfusion in children with sickle cell chest syndrome
47. Surgery in patients with hemoglobin sickle cell disease
48. Cerebrovascular accidents in sickle cell disease
49. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions
50. Post-transfusion alloimmunization in patients with sickle cell disease
51. The sickle cell hemolytic transfusion reaction syndrome
52. Iron overload and iron chelation therapy in thalassemia and sickle cell hemoglobinopathies
53. The acute chest syndrome of sickle cell disease
54. The natural history of stroke in sickle cell disease
55. Neurologic events after partial exchange transfusion for priapism in sickle cell disease
56. Splenic sequestration in sickle cell disease: Role of transfusion therapy
57. Delayed hemolytic transfusionreactions in sickle cell disease
58. The effect of ionic and nonionic contrast media on the sickling phenomenon
59. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period
60. RBC exchange pheresis for priapism in sickle cell disease
61. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease
62. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease
63. Periodic transfusion for sickle cell anemia and CNS infarction
64. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia
65. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: Implications for transfusion
66. Acute splenic sequestration crises (ASSC) in young children with sickle cell anemia. Clinical observations in 20 episodes in 14 children
67. Sickle cell intrahepatic cholestasis: Approach to a difficult problem
68. Exchange transfusion for sickle cell intrahepatic cholestasis
69. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome
70. Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low hemoglobin S level and reducing iron overload
71. The sickle cell hemolytic transfusion reaction syndrome
72. A simple, practical model for reducing alloimmunization in patients with sickle cell disease
73. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease
74. Occlusion of large cerebral vessels in sickle-cell anemia
75. Management of massive delayed hemolytic transfusion reactions in patients with sickle cell disease
76. Causes of death in sickle cell disease in Jamaica
77. Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease
78. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group
79. The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the National Sickle Cell Surgery Study Group
80. Causes and outcomes of the acute chest syndrome in sickle cell disease
81. Acute chest syndrome in sickle cell disease: Clinical presentation and course. Cooperative Study of Sickle Cell Disease
82. Consensus document for transfusion-related iron overload
83. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
84. A mimicking red blood cell autoantibody accompanying transfusion and alloimmunization
85. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
86. Evaluation and management of acute neurologic symptoms in children with sickle cell disease